←BACK

Research Article

 

Preparation and Biological Activities of Some Heterocyclic Compounds Derivatives from 2-Aminothiazoles

 

Faez Abdul-hussein Alrammahi *

 

Department of Chemistry, Faculty of Education for Girls, University of Kufa, Al-Najaf, Iraq.

 

* Corresponding author. E-mail: faez.alrammahi@uokufa.edu.iq

 

Received: Mar. 12, 2018; Accepted: May 4, 2018; Published: May 8, 2018

 

Citation: Faez Abdul-hussein Alrammahi, Preparation and Biological Activities of Some Heterocyclic Compounds Derivatives from 2-Aminothiazoles. Nano Biomed. Eng., 2018, 10(2): 129-140.

DOI: 10.5101/nbe.v10i2.p129-140.

 

Abstract:

In the current investigation, two series of 2-amino thiazole derivatives were prepared. The first series involved synthesis of (Z)-3-(thiazol-2-ylimino)indolin-2-one (A1) as Schiff base derivatives of 2-amino thiazole and isatin, then synthesis of compounds A5, A6 and A7 as five membered rings (imidazolidins) by using different amino acids, and synthesis of compounds A3 and A4 as seven membered rings (1,3-oxazepine-di-one) by using maleic and phthalic anhydrides respectively. In the second series, 2-amino thiazole was treated with acetyl acetone to form (2E,4E)-N2,N4-di(thiazol-2-yl)pentane-2,4-diimine (A2) as di-Schiff base derivatives, and finally the preparation of imidazolidin (A8) by using 2 mol of tyrosine  and preparation of tetrazole derivative (A9) by using 2 mol of sodium azide. The biological study for the above two series indicated that both gram-negative and gram-positive activities were noticed.

 

Keywords: 2-aminothiazoles; Tetrazole; Imidazolodine; Benzoxazepine; Oxazepin; Isatin; Schiff base

 

Introduction

Thiazoles are five- membered heterocyclic aromatic compound which was first prepared by A. Hantzsch [1] in 1888.  The ability of aminothiazoles to form proton-transfer complexes was developed in order to gain structural information enabling a study of the effect of amino group on 2-aminohistamine derivatives [2, 3]. The synthesis of 2-aminothiazoles derivatives has several problems including low yield, harsh reactions, difficult isolation procedures, use of expensive catalysts [4-6] and so on. Thiazole derivatives are significantly important heterocyclic compounds which exhibit a wide range of biological activities such as fungicidal [7], bactericidal [8], cardiovascular [9], antitumor [10], anti-allergic [11], central nervous system stimulate [12, 13] and antipyretic [14]. Due to the broad range of their applications, 2-aminothiazoles have been used in the synthesis of polymers [15, 16]. In this study, some of the heterocyclic compound derivatives from 2-aminothiazoles were prepared and investigated. Scheme 1 summarized pathway of the preparation of compounds A1-A9.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faas1.jpg

Scheme 1 Synthetic pathway of the preparation of compounds A1-A9

 

Experimental

Physical properties of compounds A1-A9 are listed in Table 1.

 

Table 1 Physical properties for product compounds.

Compounds

Molecular formula

Molecular weight

(gm/mol)

m. p.

()

Colors

Ylide (%)

Rf

Methanol: Benzene = 1:4

A1

C11H7N3OS

239

195

Red

78

0.62

A2

C11H12N4S2

264

107-108

Dark Brawn

67

0.76

A3

C15H9N3O4S

327

175

Red Brown

83

0.42

A4

C19H11N3O4S

377

165

black Brown

80

0.41

A5

C13H10N4O2S

166

177-179

Deep Brown

74

0.53

A6

C14H12N4O2S

300

144

Dark Red

79

0.43

A7

C11H8N6OS

277

180-181

Brown

77

0.52

A8

C29H30O4N6S2

590

165

Brown

79

0.58

A9

C11H14N10S2

350.43

174

Dark Brawn

65

0.44

 

Synthesis of (Z)-3-(thiazol-2-ylimino)indolin-2-one (A1)

Isatin (6 mmol, 0.6 g) was dissolved in (30 mL) absolute ethanol (abs. EtOH) in a 100 mL round bottom flask; two drops of glacial acetic acid (GAA) were added and stirred; 0.883 g of 6 mmol 2-aminothiazole was added. The reaction mixture was refluxed for 7 h at 70-75 . Progress of the reaction was monitored by thin layer chromatography (TLC); the resulting product was washed, dried and recrystallized from ethanol. Fourier-transform infrared spectroscopy (FTIR / cm: 1637 (υC=N, imine); 1750 (υC=O, carbonyl of indolone); 1450 and 1500 (υC=C, aromatic and vinyl and υC=N, thiazole, vib. coupling); 3450 (N-H, of indolone); 3135 (C-H, aromatic); and 767 (δo.o.p. C-H, benzene) (Fig. 1; Table 2). Proton nuclear magnetic resonance (1H- NMR): ɗ / ppm: 7.32 - 7.951 (s, 4H, phenyl); 7.271 (2H, olifinic of thiazole); and 8,049 (s, H, N-H, indolone) (Fig. 2; Table 3). Elemental analysis calculated for A1 (C11H7N3OS): C, 61; H, 3.16; N, 19.5; S, 14.6; Found C, 61.47; H, 3.28; N, 19.7; and S, 15 (Table 4).

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat1.jpg

Fig. 1 FTIR spectrum of compound A1.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat2.jpg

Fig. 2 1H-NMR spectrum of compound A1

 

Synthesis of (N,N'E,N,N'E)-N,N'-(pentane-2,4-diylidene)bis(thiazol-2-amine) (A2)

0.3 g of 3 mmol acetyl acetone was dissolved in 30 mL abs. EtOH in a 100 mL round bottom flask; three drops of GAA were added and stirred; 0.6 g of 6 mmol 2-aminothiazole was added. The reaction mixture was refluxed for 8 h at 70 . Progress of the reaction was monitored by TLC. The resulting product was washed, dried and recrystllizaed from ethanol. FTIR / cm: 1608 (υC=N, imine); 1589 and 1500 (υC=C, vinyl and υC=N, thiazole, vib. coupling); 3450 (N-H, of indolone); 3182 (C-H, aromatic); 2972 (C-H, methyl); 1442 (C-N, thiazole); and 1041.6 (C-S, thiazole) (Fig. 3; Table 2). H1- NMR: ɗ / ppm: 1.408 (s, 6H, methyl); 6,917-7.271 (2H, olifinic of thiazole); and 2.419 (s, CH2) (Fig. 4; Table 3). Elemental analysis for A1 (C11H7N3OS): C, 61; H, 3.16; N, 19.5; S, 14.6; Found C, 61.47; H, 3.28; N, 19.7; and S, 15 (Table 4).

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat3.jpg

Fig. 3 FTIR spectrum of compound A2.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat4.jpg

Fig. 4 1H-NMR spectrum of compound A2.

 

Synthesis of 3'-(thiazol-2-yl)-3'H-spiro[indoline-3,2'-[1,3]oxazepine]-2,4',7'-trione (A3)

A mixture (6 mmol, 0.128 g) of compound A1 and 0.059 g of 6 mmol maleic anhydride were refluxed in 30 mL benzene, at 60 for about 20 h, and then recrystllizaed from ethanol. FTIR / cm: 1680 (υC=O, amide); 1735 (υC=O, carbonyl of indolone and ester); 1618 and 1462 (υC=C, aromatic and vinyl, vib. coupling); 3400 (N-H, of indolone); 3192 (C-H, aromatic); and 750 (δo.o.p. C-H, benzene) (Fig. 5; Table 2). H1- NMR: ɗ / ppm: 7.584 - 7.484 (s, 4H, phenyl); 7.009-6.577 (2H, olivinic of oxazepine); 6.390 (2H, olivinic of thiazole); and 8,094 (s, H, N–H, indolone) (Fig. 6; Table 3). Elemental analysis for A3 (C15H9N3O4S): C, 54.5; H, 2.5; N, 12.24; S, 14.6; Found C, 55.02; H, 2.72; N, 12.80; and S, 9.71 (Table 4).

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat5.jpg

Fig. 5 FTIR spectrum of compound A3.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat6.jpg

Fig. 6 1H-NMR spectrum of compound A3.

 

Synthesis of 4-(thiazol-2-yl)-1H-spiro[benzo[e][1,3]oxazepine-3,3'-indoline]-1,2',5(4H)-trione (A4)

A mixture (6 mmol, 0.128 g) of compound A1 and 0.089 g of 6 mmol phthalic anhydride were refluxed in 30 mL benzene, at 75 for about 24 h, and then recrystllizaed from ethanol. FTIR / cm: 1727 (υC=O, amide); 1651 (υC=O, carbonyl of indolone and ester); 1618 .8 (υC=C, aromatic and vinyl, vib. coupling); 3381 (N-H, of indolone); 3194 (C-H, aromatic); and 669 (δo.o.p. C-H, benzene) (Fig. 7; Table 2). Elemental analysis for A4 (C19H11N3O4S): C, 60.00; H, 2.86; N, 10.98; S, 8.35; Found C, 60.47; H, 2.91; N, 11.14; and S, 8.48 (Table 4).

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat7.jpg

Fig. 7 FTIR Spectrum of compound A4.

 

Synthesis of 1-(thiazol-2-yl)spiro[imidazolidine-2,3'-indoline]-2',5-dione (A5)

A mixture (0.47 mmol , 0.085 g) of compound A1 and 0.03 g of 0.47 mmol glycine (an amino acid) were refluxed in 30 mL tetrahydrofuran (THF), at 70 for about 24 h, and then recrystallized from ethanol. FTIR / cm: 1738 (υC=O, amide); 1506 (υC=N, carbonyl); 1620 (υC=C, aromatic and vinyl, vib. coupling); 3292 and 3194 (2N-H, of indolone and imidazolodine); 3052 (C-H, aromatic); 2956 (C-H, aliphatic); and 656 (δo.o.p. C-H, benzene) (Fig. 8; Table 2).

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat8.jpg

Fig. 8 FTIR spectrum of compound A5.

 

Synthesis of 4-methyl-1-(thiazol-2-yl)spiro[imidazolidine-2,3'-indoline]-2',5-dione (A6)

A mixture (6 mmol, 0.128 g ) of compound A1 and  0.089 g of 6 mmol alanine (an amino acid) were refluxed in 30 mL THF, at 70 for about 24 h, and then recrystallized from ethanol. FTIR / cm: 1725 (υC=O); 1651 (υC=O, carbonyl of amide); 1620 (υC=C, aromatic and vinyl); 3300 and 3194 (2N-H, of indolone and imidazolodine); 1512 (νC = N, of thiazole); 3050 (C-H, aromatic); 2928 (C-H, alphatic); and 677 (δo.o.p. C-H, benzene) (Fig. 9; Table 2). Elemental analysis for A6 (C14H12N4O2S): C, 60.00; H, 2.86; N, 10.98; S, 8.35; Found C, 60.47; H, 2.91; N, 11.14; and S, 8.48.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat9.jpg

Fig. 9 FTIR spectrum of compound A6.

 

Synthesis of 1'-(thiazol-2-yl)-1',2'-dihydrospiro[indoline-3,5'-tetrazol]-2-one (A7)

A mixture (4.7 mmol, 0.1 g) of compound A1 and 0.031 g of 4.7 mmol sodium azide were refluxed in 20 mL THF, at 70 for about 12 h, and then recrystallized from ethanol. FTIR / cm: 3487 and 3250 (2N-H, of tetrazole); 2856 (C-H, aliphatic); 1622 (υC=C, of vinyl in thiazole); 1629 (υC=N, of thiazole); 1508 (υN=N, of tetrazole); and 667 (δo.o.p. C-H, benzene) (Fig. 10; Table 2).

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat10.jpg

Fig. 10 FTIR spectrum of compound A7.

 

Synthesis of (2S,2'R)-2,2'-methylenebis(5-(4-hydroxybenzyl)-2-methyl-3-(thiazol-2-yl)imidazolidin-4-one) (A8)

A mixture (1.5 mmol, 0.396 g ) of compound A2 and 0.543 g of 3 mmol tyrosine (an amino acid) were refluxed in 30 mL THF, at 70 for about 24 h, and then recrystallized from ethanol. FTIR / cm: 1608 (υC=N, imine); 1589 and 1500 (υC=C, vinyl and υC=N, thiazole, vib. coupling); 3450 (N-H, indolone); 3182 (C-H, aromatic); 2972 (C-H, methyl); 1442 (C-N thiazole); and 1041.6 (C-S thiazole) (Fig. 11; Table 2). H1- NMR: ɗ / ppm): 1.408 (s, 6H, methyl); 6,917-7.271 (2H, olifinic of thiazole); and 2.419 (s, CH2) (Fig. 12; Table 3). Elemental analysis for A8 (C29H30O4N6S2): C, 61.09; H, 4.91; N, 14.84; S, 11.33; Found C, 61.45; H, 5.03; N, 15.17; and S, 11.52 (Table 4).

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat11.jpg

Fig. 11 FTIR spectrum of compound A8.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat12.jpg

Fig. 12 1H-NMR spectrum of compound A8.

 

Synthesis of ((R)-5-methyl-1-(thiazol-2-yl)-2,5-dihydro-1H-tetrazol-5-yl)((S)-5-methyl-1-(thiazol-2-yl)-2,5-dihydro-1H-tetrazol-5-yl)methane (A9)

A mixture (1.0 mmol , 0.264 g ) of compound A2 and 0.13 g of 2.0 mmol sodium azide were refluxed in 30 mL dimethyl sulfoxide (DMSO), at 70 for about 14 h, and then recrystallized from ethanol. FTIR / cm: 3400 and 3363 (N-H, of tetrazole); 2856 (C-H, aliphatic); 1629 (υC=N, of thiazole); and 1592 (υC=N, thiazole) (Fig. 13; Table 2).

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat13.jpg

Fig. 13 FTIR spectrum of compound A9.

 

Table 2 FTIR for product compounds A1-A9

FTIR / cm

Compounds

Aliphatic

υ(C-H)

Aromatic

υ(C-H)

Aromatic

υ(C=C)

Imine

υ(C=N)

Amide

υ(C=O)

 

2900

3135

1450.09

1637

1750

A1

Thiazole

υ(C-S)

Thiazole

υ(C-N)

Aromatic

υ(C-H)

Aliphatic

υ(C-H)

Thiazole

υ(C=N)

Imine

υ(C=N)

 

1041

1442

3182

2972

1589

1608.96

A2

 

Amine

υ(NH)

Aliphatic

υ(C-H)

Aromatic

υ(C-H)

Alkene

υ(C=C)

Amide

υ(C=O)

Ester

υ(C=O)

 

3400

2985

3194

1618, 1462

1680

1735

A3

3381

2995

3194

1618

1651

1724

A4

Hydroxyl

υ(OH)

Thiazole

υ(C=N)

Aromatic

υ(C-H)

Aliphatic

υ(C-H)

Alkene

υ(C=C)

Amine

υ(NH)

Ketone

υ(C=O)

 

--

1506

3052

2956

1620

3194, 3292

1738, 1653

A5

--

1512

3050

2928

1620

3194, 3300

1725

A6

3415

1525

3120.82

2962

1627

3300

1735.93

A8

Aliphatic

υ(C-H)

Amine

υ(NH)

Imine

υ(C=N)

Azo

υ(N=N)

Keton

υ(C=O)

 

2856

3250, 3487

1629

1508.38

1745

A7

2956

3363

1592

1560

--

A9

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Table 3 H1-NMR for product compounds A1, A2, A3 and A8

Compounds

Molecular formula.

OH hydroxyl

CH aromatic

CH

olivine of oxazepine

CH

olivine of

thiazole

NH

indolone

CH3 methyl

CH2+

CH2-phenyl

A1

C11H7N3OS

--

7.32 - 7.951

--

7.271

8,049

--

--

A2

C11H12N4S2

--

--

--

6,917 - 7.271

--

1.408

2.419

A3

C15H9N3O4S

--

7.584 - 7.484

7.009 - 6.577

6.390 - 6.244

8,094

--

--

A8

C29H30O4N6S2

9.014

7.772 - 7.416

--

7.929

7.947 - 7.839

2.503

3.329 -

7.016

 

Table 4 Elemental analysis for product compounds A1, A3, A4, A6 and A8

O%

S%

N%

H%

C%

Calculated / Observed

Molecular formula

Compounds

6.99

14.40

19.00

3.16

58.22

Cal.

C11H7N3OS

A1

--

14.00

18.57

3.28

57.47

Obs.

19.55

9.20

12.24

2.50

54.53

Cal.

C15H9N3O4S

A3

--

9.71

12.80

2.72

55.02

Obs.

16.96

8.35

10.98

2.86

60.00

Cal.

C19H11N3O4S

A4

--

8.48

11.14

2.91

60.47

Obs.

10.66

10.18

18.21

3.40

55.89

Calc.

C14H12N4O2S

A6

--

10.7

18.65

3.67

56.10

Obs.

10.83

11.33

14.84

4.91

61.09

Cal.

C29H30O4N6S2

A8

--

11.52

15.17

5.03

61.45

Obs.

 

 

 

 

 

 

 

 

 

 

 

Results and Discussion

Biological activity

According to the World Health Organization (WHO), microorganisms are still the main obstacle to the treatment of infectious diseases, and the preparation of therapeutic agents as a highly selective antimicrobials within the limits of specific concentrations [17. 18]. Five types of pathogenic bacteria were used in the current study, two of them were gram-negative and the other three were gram-positive. The sensitivity was calculated using 1000 ppm degree drilling method, and the employed solvent was DMF [19, 20]. The composition of bacterial cell walls in the gram-negative bacteria presented lower thickness and higher lipophilicity as compared with those of the gram-positive bacteria, thus facilitating the passage of compounds which could be dissolved into the fatty compounds and transferred into the cell. These compounds inhibited the capture. The bacterial growth through the hardiness of the active sites depended on the Overton concept, the phenomenon of plasmolysis, i.e. a retraction of the protoplasm from the cellulose wall of plant cells exposed to impermeable external solutes. (Overton's system explored the relationship between the chemical constitution of solutes, mainly organic, and their plasmolytic effects, with reference to the properties of the putative osmotic barrier) [21-24]. These sites for respiration and protein synthesis inhibit the formation of hydrogen bonds of some interface-active center. Certain cell components or enzymes cause them to stop and change the natural states of cell, leading ultimately to cell death [25]. Table 4 shows the results of biological activity data and the inhibition range in millimeters. Fig. 14 illustrates bacteria wall and the method of using a gram dye to differentiate between gram-positive and gram-negative bacteria. Statistical representation for antibacterial activity of compounds A1-A9 is shown in Fig. 15 and Table 15.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat14.jpg

Fig. 14 Bacteria wall and the method of using a gram dyes to differentiate between gram-positive and gram-negative bacteria.

 

D:\xwu\Nano Biomedicine and Engineering\Articles for production\排版\10(2)\0011 p129-140 OK\129-140\faat15.jpg

Fig. 15 Statistical representation for antibacterial activity of compounds A1-A9.

 

Table 5 Biological activity data (zone of inhibition in mm) of the compounds A1-A9.

 

Compounds

Bacteria

Gram-negative

Gram-positive

 

K. pneumoniae

P. aeruginosa

P. mirabillis

S. epidermidis

S. aureus

A1

13

14

15

11

10

A2

10

11

12

9

7

A3

13

13

11

8

9

A4

11

11

12

7

8

A5

12

12

10

9

7

A6

13

10

12

8

8

A7

15

12

13

7

8

A8

13

13

14

10

11

A9

13

12

12

8

9

 

Conclusions

Two series of 2-amino thiazole derivatives were prepared and characterized in this study. FTIR spectroscopy and NMR technique confirmed the formation of these derivatives. Five types of pathogenic bacteria were used, two of them were gram-negative and the other three were gram-positive. A significant biological activity was observed for the above compounds.

 

Conflict of Interests

The authors declare that no competing interest exists.

 

References

  1. M. Sheikhi, New derivatives of (E, E)-azomethines: Design, quantum chemical modeling, spectroscopic (FT-IR, UV/Vis, polarization) studies, synthesis and their applications: Experimental and theoretical investigations. Journal of Molecular Structure, 2018, 1152: 368-385.
  2. H. Chen, Degradation of azo dye Orange II under dark ambient conditions by calcium strontium copper perovskite. Applied Catalysis B: Environmental, 2018, 221: 691-700. 
  3. G. Agnieszka, Synthesis, structure, DNA binding and anticancer activity of mixed ligand ruthenium (II) complex. Journal of Molecular Structure, 2018, 1155: 288-296.
  4. S. Shubha, S. Biju, and V. Sadasivan, Synthesis, structure characterization and biological studies on a new aromatic hydrazone, 5-(2-(1, 5-dimethyl-3-oxo-2-phenyl-2, 3-dihydro-1H-pyrazol-4-yl) hydrazono)-2, 2-dimethyl-1, 3-dioxane-4, 6-dione, and its transition metal complexes. Journal of Molecular Structure, 2018, 1156: 201-209.
  5. T. Heraert, Metabolic studies on histidine, histamine, and related imidazoles. Pharmacological reviews, 1954, 6: 299-343.
  6. R. Kenchappa, Y. Bodke, Antifungal and anthelmintic activity of novel benzofuran derivatives containing thiazolo benzimidazole nucleus: an in vitro evaluation. Journal of Chemical Biology, 2017, 10(1): 11-23
  7. M.V. Papadopoulou, W.D. Bloomer, and H.S. Rosenzweig, The antitubercular activity of various nitro (triazole/imidazole)-based compounds. Bioorganic & Medicinal Chemistry, 2017, 25(21): 6039-6048.
  8. R.T. Iminov, TA.V. verdokhlebov, A.A. Tolmachev, et al., Simple and convenient synthesis of 2, 3, 4, 5-tetrahydro-1, 5-dioxopyrrolo [1, 2-a] quinazoline-3a (1H)-carboxylic acids in multi-gram scale. Heterocycles, 2008, 75(7): 1673-1680.
  9. N. Liu, D. Ding, L. Wang, et al., Two novel Mg (II)-based and Zn (II)-based complexes: inhibiting growth of human liver cancer cells. Brazilian Journal of Medical and Biological Research, 2018, 51(2): 12-19.
  10. K. Karrouchi, S. Radi, Y. Ramli, et al., Y., Synthesis and Pharmacological Activities of Pyrazole Derivatives: A Review. Molecules, 2018, 23(1): 134-142.
  11. P. Palanisamy, S.J. Jenniefer, and P.T. Muthiah, Synthesis, characterization, antimicrobial, anticancer, and antituberculosis activity of some new pyrazole, isoxazole, pyrimidine and benzodiazepine derivatives containing thiochromeno and benzothiepino moieties. RSC Advances, 2013, 3(42): 19300-19310.
  12. M.A. Metwally, Y.A. Suleiman, M.A. Gouda, et al., Synthesis, antitumor and antioxidant evaluation of some new antipyrine based azo dyes incorporating pyrazolone moiety. Int. J. Mod. Org. Chem., 2012, 1(3): 213-225.
  13. R.E. Hoover, R.A. Day, Preparation of some imidazole derivatives of 1, 4-naphthoquinone. Journal of the American Chemical Society, 1954, 76(16): 4148-4152.  
  14. S. Shozo, F. Masamichi, and N. Ryozo, Syntheses of azo dyes containing 4, 5-diphenylimidazole and their evaluation as analytical reagents. Analytica Chimica Acta, 1976, 81: 131-141.
  15. H. Huheey, E.A. Keiter, and R.L. Keiter, Inorganic chemistry: principles of structure and reactivity, 4th ed. Harper Collin College Publishers, 1993: 122-124.
  16. N. Raman, J.D. Raja, Synthesis, structural, characterization and antibacterial studies of some bio sensitive mixed ligand copper (II) complexes. Indian J. Chem., 2007, 46A:1611-1614.
  17. A.S. Al-Rammahi, A.H. Al-khafagy, Synthesis and characterization of oxazepen and imidazolin derivatives from 2-amino -5- mercapto 1,3,4 - thiadiazol and studing of their biological activity. Word J. pharm. Res., 2015, 4(2): 1668-1680.
  18. A.H. Al-Khafagy, Synthesis, characterization and biological study of some new metal - azo chelate complexes. J. Chem. Pharm. Res., 2016, 8(8): 296-302.
  19. A.A. Saeyda, Synthesis and characterization of some metal complexes derived from azo compound of 4, 4-methylenedianiline and antipyrine: Evaluation of their biological activity on some land snail species. Journal of Molecular Structure, 2015, 1099: 567-578.
  20. S. Suhad, Synthesis and spectral studies of heterocyclic azo dye complexes with Y (III) and La (III) ions. Al-Qadisiyah Journal of Pure Science, 2017, 19(1): 67-77.
  21. T. Giuseppe, Ligating properties of thionitrosoamines: I. Neutral mononuclear N-thionitrosodimethylamine-palladium (II) and-platinum (II) complexes. Journal of Organometallic Chemistry, 1983, 252(3): 381-387. 
  22. B. Anupamp, C. Kumari Gyana, Cobalt (II) complexes of ONO donor Schiff bases and N,N donor ligands: Synthesis, characterization, antimicrobial and DNA binding study. International Journal of Research in Chemistry and Environment, 2013, 3(2): 172-180. 
  23. P.A.L. Sanjib, Synthesis, spectral and electrochemical properties of 1-alkyl-2-(naphthyl-β-azo) imidazole complexes of platinum (II) and the reaction with pyridine bases. Single-crystal X-ray structure of dichloro-[1-ethyl-2-(naphthyl-β-azo) imidazole] platinum (II). Polyhedron, 2000, 19(10): 1263-1270. 
  24. M. Kurtoğlu, M. Baydemir, and S. Ayşe, Studies on mononuclear transition metal chelates derived from a novel (E, E)-dioxime: Synthesis, characterization and biological activity. Journal of Coordination Chemistry, 2007, 60(6): 655-665.
  25. K. Nakamoto, Infrared and Raman spectra of inorganic and coordination compounds, 6th ed. John Wiley & Sons, Inc., 2009: 131-142.

 

Copyright© Faez Abdul-hussein Alrammahi. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Nano Biomedicine and Engineering.

Copyright © Shanghai Jiao Tong University Press